The involvement of autophagy in melanoma vasculogenic mimicry

Introduction. Autophagy, a catabolic process of protein and organelle recycling by transferring defective cytoplasm and organelles into double-membraned vesicles to degrade and regenerate materials, plays a critical role in maintaining energy homeostasis. Autophagy also protects against stress and infection, participates at the development of autoimmune disease. In recent years, the existence of alternative blood circulation system in tumors, vasculogenic mimicry (VM), which can partially compensate the lack of nutrients and oxygen under the hypoxic conditions, has been described. Objective. To elucidate the relationship between autophagy and VM. Materials and methods. In this study we used 2D- and 3D-culturing of melanoma cells derived from surgical species of patients with disseminated melanoma, electrophoresis and western blot, knockdown of the genes by using small interfering RNA (siRNA), flow cytometry, fluorescence microscopy. Results. We detected the basal level autophagy by examining the expression of autophagy-specific protein (LC-3B) by flow cytometry and cellular immunofluorescence staining by monodancylcadaverine. Both assays are the markers of autophagy late stage. Here we show that the level of autophagy in melanoma cells mel P, participated in capillary-like structures (CLS) formation in matrigel, was considerably higher than in mel Me cells which do not involve in VM. To explore the function of autophagy in the ability of melanoma cells to form CLS 3-methyladenine (3-MA) or chloroquine - inhibitors of initiation and terminal stage of autophagy - were used. Both inhibitors reduced the ability of melanoma cells to engage in VM. The data obtained were confirmed by siRNA-mediated gene silencing of BECN1 involved in the initiation of autophagy and ATG5 gene which is considered to be a marker of late stage of autophagy. Knockdown of BECN1 or ATG5 in mel P melanoma cells reduced the level of protein Beclin-1 and Atg5 about 70-75 %, and suppressed CLS formation in matrigel. Melanoma cells with the ATG5 gene knockdown changed the shape but maintained the ability to migrate and recognize each other, the formation of CLS was not observed. Low molecular weight VM inhibitor LCS-1269, significantly reduced the basic level of autophagy. Conclusion. Our data indicate that autophagy participates in CLS formation, and inhibition of autophagy suppresses CLS formation. We suggest that autophagy plays a dual role in the survival and development of tumors: autophagy helps cancer cells against environment stress and provides a temporary survival pathway by promoting energy regeneration, autophagy also promotes VM formation which supplies nutrients and oxygen to less vascularized area of tumor.

меланома, аутофагия, васкулогенная мимикрия, autophagy, melanoma, vasculogenic mimicry

1. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011;147(4):728-41. DOI: 10.1016/j.cell.2011.10.026. PMID: 22078875.

2. Singh R., Cuervo A.M. Autophagy in the cellular energetic balance. Cell Metab 2011;13(5):495-504. DOI: 10.1016/j.cmet. PMID: 21531332.

3. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001;8(6):569-81. DOI: 10.1038/sj.cdd.4400852. PMID: 11536007.

4. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010;330(6009):1344-8. DOI: 10.1126/science.1193497. PMID: 21127245.

5. Guo J.Y., Xia B., White E. Autophagy-mediated tumor promotion. Cell 2013;155(6):1216-9. DOI: 10.1016/j.cell.2013.11.019. PMID: 24315093.

6. Degenhardt K., Mathew R., Beaudoin B. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006;10(1):51-64. DOI: 10.1016/j.ccr.2006.06.001. PMID: 16843265.

7. Sun K., Deng W., Zhang S. et al. Paradoxical roles of autophagy in different stages of tumorigenesis: protector for normal or cancer cells. Cell Biosci 2013;3(1):35-42. DOI: 10.1186/2045-3701-3-35.

8. Gerger A., LaBonte M., Lenz H.L. Molecular predictors of response to antiangiogenesis therapies. Cancer J 2011;17(2):134-41. DOI: 10.1097/PPO.0b013e318212db3c. PMID: 21427557.

9. Cantelmo A.R., Pircher A., Kalucka J. et. al. Vessel pruning or healing: endothelial metabolism as a novel target? Expert Opin Ther Targets 2017;21(3):239-47. DOI: 10.1080/14728222.2017.1282465. PMID: 28081641.

10. Folberg R., Maniotis A.J. Vasculogenic mimicry. APMIS 2004;112(7-8):508-25. DOI: 10.1111/j.1600-0463.2004. apm11207-0810.x. PMID: 15563313.

11. Михайлова И.Н., Лукашина М.И., Барышников А.Ю. и др. Клеточные линии меланомы - основа для создания противоопухолевых вакцин. Вестник РАМН 2005;7:37-40.

12. Kimlin L.C., Casagrande G., Virador V.M. In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog 2013;52(3):167-82. DOI: 10.1002/mc.21844. PMID: 22162252.

13. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007;130(4):601-10. DOI: 10.1016/j.cell.2007.08.006. PMID: 17719539.

14. Amaravadi R.K., Lippincott-Schwartz J., Yin X.M. et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011;17(4):654-66. DOI: 10.1158/1078-0432. PMID: 21325294.

15. Ding Y., Zhao K., Wu Y., Xing C. Expression and significance of Beclin-1 in vasculogenic mimicry formation of gastric cancer. Oncol Rep 2014;17(7):716-9. PMID: 25070456.

16. Hönscheid P., Datta K., Muders M.H. Autophagy: detection, regulation and its role in cancer and therapy response. Int J Radiat Biol 2014;90(8):628-35. DOI: 10.3109/09553002. PMID: 24678799.

17. Pyo J.O., Nah J., Jung Y.K. Molecules and their functions in autophagy. Exp Mol Med 2012;44(2):73-80. DOI: 10.3858/emm.2012.44.2.029. PMID: 22257882.

18. Barth S., Danielle Glick D., Kay F., Macleod K.F. Autophagy: assays and artifacts. J Pathol 2010;221(2):117-24. DOI: 10.1002/path.2694. PMCID: PMC2989884.

19. Вартанян А.А., Барышникова М.А., Эктова Л.В. и др. Производные индолкарбазолов, блoкирующие васкулогенную мимикрию в опухоли. Патент РФ № 2557554. Бюлл. № 21, 2015.

20. Ozpolat B., Benbrook D.M. Targeting autophagy in cancer management -strategies and developments. Cancer Manag Res 2015;7:291-9. DOI: 10.2147/CMAR.S34859. PMID: 26392787.

21. Menzies F.M., Fleming A., Rubinsztein D.C. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci 2015;16(6):345-57. DOI: 10.1038/nrn3961. PMID: 25991442.